Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBSXBoston Scientific
FinDog View：Neutral
GILDGilead Sciences
FinDog View：Neutral
| Metric | BSX | GILD |
|---|
| Close | 41.98 | 170.68 |
| Market Cap | $61.1B | $213B |
| 1M | −3.83% | +14.51% |
| P/E (TTM) | 16.8 | — |
| Forward P/E | 13.2 | 22.0 |
| P/E 5-Yr Percentile | 0 | — |
| P/S | 3.0 | 7.0 |
| P/B | 2.5 | 17.9 |
| Dividend Yield | — | 3.98% |
| Latest Quarter Revenue | $5.4B | $8.3B |
| Revenue YoY | +7.5% | +6.8% |
| Gross Margin | 70.7% | 81.1% |
| Latest Quarter EPS | 0.61 | 1.94 |
| Avg Post-Earnings Move | ±1.5% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 2.57% |
| 90-Day Net Insider Buying | +$9.5M | −$15.9M |
BSX · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
